Search - tctmd.com

Displaying 121 - 130 of 130

Sort: Relevancy | Date

News Daily News

膳食指南更新版的焦点转向健康饮食习惯

Todd Neale

January 18, 2016

News Daily News

La Actualización de las Directrices sobre la Dieta Cambia el Centro de Atención a Patrones Alimenticios Saludables

Todd Neale

January 18, 2016

News Daily News

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Todd Neale

January 06, 2016

News Industry News

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

January 03, 2016

News Daily News

含糖饮料对全球心脏代谢健康的威胁越来越大

Todd Neale

December 02, 2015

News Daily News

Sugary Drinks an Increasing Threat to Global Cardiometabolic Health

Todd Neale

December 02, 2015

News Daily News

Las Bebidas Azucaradas son una Amenaza contra la Salud Cardiometabólica Global

Todd Neale

December 02, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Industry News

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

August 20, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

Advertisement

膳食指南更新版的焦点转向健康饮食习惯

La Actualización de las Directrices sobre la Dieta Cambia el Centro de Atención a Patrones Alimenticios Saludables

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

含糖饮料对全球心脏代谢健康的威胁越来越大

Sugary Drinks an Increasing Threat to Global Cardiometabolic Health

Las Bebidas Azucaradas son una Amenaza contra la Salud Cardiometabólica Global

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content